{"lastModified":"2025-09-24T22:00:37","links":[{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacja.xsp?typ=int&nr=11564","rel":"web-description"},{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacjaTresc.xsp?key=DKVGZK","rel":"web-body"},{"href":"https://api.sejm.gov.pl/sejm/term10/interpellations/11564/body","rel":"body"}],"num":11564,"receiptDate":"2025-08-04","term":10,"title":"Interpelacja w sprawie rozważenia włączenia do programu lekowego terapii skojarzonej pertuzumabem i trastuzumabem w formie podskórnej (Phesgo) dla pacjentek z rakiem piersi","answerDelayedDays":0,"from":["182","431"],"recipientDetails":[{"answerDelayedDays":0,"name":"minister zdrowia","sent":"2025-08-25"}],"replies":[{"attachments":[{"URL":"https://api.sejm.gov.pl/sejm/term10/interpellations/attachment/ATTDLTJLX/i11564-o1.pdf","lastModified":"2025-09-24T22:00:37","name":"i11564-o1.pdf"}],"from":"Podsekretarz stanu Katarzyna Anna Kacperczyk","key":"DLTJLX","lastModified":"2025-09-24T22:00:37","links":[{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacjaTresc.xsp?key=DLTJLX","rel":"web-body"},{"href":"https://api.sejm.gov.pl/sejm/term10/interpellations/11564/reply/DLTJLX/body","rel":"body"}],"onlyAttachment":true,"prolongation":false,"receiptDate":"2025-09-23"}],"sentDate":"2025-08-25","to":["minister zdrowia"]}